Cargando…
Direct Inhibition of Microglia Activation by Pretreatment With Botulinum Neurotoxin A for the Prevention of Neuropathic Pain
Peripheral injection of botulinum neurotoxin A (BoNT/A) has been demonstrated to have a long-term analgesic effect in treating neuropathic pain. Around peripheral nerves, BoNT/A is taken up by primary afferent neurons and inhibits neuropeptide release. Moreover, BoNT/A could also be retrogradely tra...
Autores principales: | Feng, Xiaona, Xiong, Donglin, Li, Jie, Xiao, Lizu, Xie, Weijiao, Qiu, Yunhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688716/ https://www.ncbi.nlm.nih.gov/pubmed/34949981 http://dx.doi.org/10.3389/fnins.2021.760403 |
Ejemplares similares
-
Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020) -
Transient Receptor Potential Channels and Botulinum Neurotoxins in Chronic Pain
por: Go, Eun Jin, et al.
Publicado: (2021) -
Oxytocin Relieves Neuropathic Pain Through GABA Release and Presynaptic TRPV1 Inhibition in Spinal Cord
por: Sun, Wuping, et al.
Publicado: (2018) -
Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing
por: Pellett, Sabine, et al.
Publicado: (2015) -
The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes
por: Marinelli, Sara, et al.
Publicado: (2012)